Reservoir Dry Powder Inhaler (RDPI®)
Our validated proprietary reservoir DPI platform is available to deliver a broad range of complex inhaled therapies, both novel and generics.
Can be used to deliver wide range of drugs
from small molecules to proteins.
Can deliver large doses into lungs
with high lung delivery efficiency due to large surface area (80-120m2), good vascularisation, immense capacity for exchange and ultra thinness of the alveolar epithelium.
Replicate critical functions of existing inhaler devices
(metered dose, Reservoir DPI, Blister based DPI,…).
Rapid onset of action with no degration in GI tract
Improved PK profile compared to oral delivery
with no first pass hepatic effect and less drug reducing side-effects.
Our Mission
We design, develop and manufacture affordable and technically-feasible advanced inhaled drug solutions to bring local or systemic therapy to the world.
​​
-
Combining our formulations and device platforms to create unique inhaled drug solutions,
-
Scaling-up from laboratory through to commercial scale including stability and dossier.
